Home Consumer Eight Cancers Could Be Diagnosed With A Single Blood Test

Eight Cancers Could Be Diagnosed With A Single Blood Test

CancerSEEK

For many cancers, diagnosis is a long and challenging process. A new blood test, however, could offer a much-needed simpler and more effective diagnostic technique. Called CancerSEEK, it has the potential to identify eight cancer types from one blood sample.

In the new study, researchers reveal how the blood test demonstrated high sensitivity and specificity for cancer detection in more than 1,000 people with the disease.

The team — from the Johns Hopkins University School of Medicine in Baltimore, MD — recently published their results in the journal Science.

Worldwide, cancer remains one of the leading causes of death. It is estimated that by 2030, the number of cancer deaths will have risen from 8 million to 13 million.

Faith Based Events

Early diagnosis is key to reducing cancer-related deaths; the earlier the disease is diagnosed, the higher the chances of treatment success. But sadly, many cancers are not caught until the later stages, and this is largely due to a lack of fast and effective diagnostic tools.

However, the Johns Hopkins researchers believe that CancerSEEK could bring us closer to a quick, simple way to detect cancer in its early stages.

Test produced high sensitivity and specificity

When cancerous tumors form, they release small fragments of mutated DNA and proteins into the bloodstream, and these can act as markers for cancer.

The new blood test works by identifying the markers for 16 gene mutations and eight proteins that are associated with eight different cancer types. These include breast, lung, and colorectal cancer, as well as five cancers — ovarian, liver, stomach, pancreatic, and esophageal — for which there are currently no routine screening tests for people at average risk.

“A novelty of our classification method is that it combines the probability of observing various DNA mutations together with the levels of several proteins in order to make the final call,” explains study co-author Cristian Tomasetti, Ph.D., an associate professor of oncology and biostatistics at Johns Hopkins University.

[vc_btn title=”Continue reading” style=”outline” color=”black” link=”url:https%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F320679.php%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3DMNT%2520Daily%2520Full%2520%2528non-HCP%2520US%2529%2520-%2520OLD%2520STYLE%25202018-01-19%26utm_term%3DMNT%2520Daily%2520News%2520%2528non-HCP%2520US%2529|title:Continue%20reading|target:%20_blank|”][vc_message message_box_style=”outline” message_box_color=”black”]MedicalNewsToday, excerpt posted on SouthFloridaReporter.com, Jan. 20, 2018[/vc_message]

Disclaimer

The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components